Pluristem
Israeli breakthrough company seeks to use cells to improve quality of life
The biotechnology company Pluri, is expanding its activities and establishing strategic collaborations for the development and marketing of food-tech and pharmaceutical products.
Israel's Tnuva partners with Pluristem to develop cultured cell-based meat
Israel: The 'Start-Up Nation' is now the 'Biotech Nation' - opinion
Pluristem CEO touts a new generation of medical treatments
Israeli COVID-19 treatment shows 100% survival rate - preliminary data
Not only have all the patients survived, according to Pluristem, but four of them showed improvement in respiratory parameters.
Pluristem’s potential new breakthrough
Haifa company weeks away from presenting clinical trial results that could ‘generate hope’ for patients suffering from untreatable vascular disease.
Smart cells that heal
Innovative Israeli cell therapy could step up treatment of CLI.
New hope for cancer patients
Cancer is a leading cause of death around the world and its incidence continues to rise. Each year around 12.7 million people discover they have cancer and 7.6 million people die from it.
USFDA clears Plursitem for expanded access program
Patients suffering from critical limb ischemia can now benefit without being part of clinical trials
The Israeli company developing radiation countermeasures for the US government
Imagine a scenario where cells and tissues can be engineered to secrete a range of therapeutic proteins that can help the body generate its own healing process.
